CANCER MANAGEMENT AND RESEARCH Journal

publication venue for

First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy. 11:10463-10476. 2019
Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes 2022

International Standard Serial Number (ISSN)

1179-1322

journal abbreviation

CANCER MANAG RES